Poul Sorensen, director of Geistlich Pharma in Brazil, details the importance of educational activities for Geistlich’s business, the affiliate’s desire to bring new segments of Geistlich’s portfolio to Brazil and the necessity of adapting the business strategy to each region in Brazil according to their price sensitivity.
Could you introduce the Brazilian arm of Geistlich, its history and the scope of your operations in the country?
"Our focus is on evidence-based product development and education, aligned with an adequate geographical coverage over the country."
